192 related articles for article (PubMed ID: 21750116)
21. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.
Lu X; Bijli KM; Ramirez A; Murphy TC; Kleinhenz J; Hart CM
Free Radic Biol Med; 2013 Oct; 63():151-60. PubMed ID: 23684777
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells.
Abdel-Latif MM; Windle H; Terres A; Eidhin DN; Kelleher D; Reynolds JV
J Gastrointest Surg; 2006 Apr; 10(4):551-62. PubMed ID: 16627221
[TBL] [Abstract][Full Text] [Related]
23. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
Ogunwobi O; Mutungi G; Beales IL
Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
[TBL] [Abstract][Full Text] [Related]
24. Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.
Taylor C; Loomans HA; Le Bras GF; Koumangoye RB; Romero-Morales AI; Quast LL; Zaika AI; El-Rifai W; Andl T; Andl CD
Oncotarget; 2015 Oct; 6(33):34228-44. PubMed ID: 26447543
[TBL] [Abstract][Full Text] [Related]
25. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.
Tselepis C; Perry I; Dawson C; Hardy R; Darnton SJ; McConkey C; Stuart RC; Wright N; Harrison R; Jankowski JA
Oncogene; 2002 Sep; 21(39):6071-81. PubMed ID: 12203119
[TBL] [Abstract][Full Text] [Related]
26. Molecular regulation of NADPH oxidase 5 via the MAPK pathway.
Pandey D; Fulton DJ
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1336-44. PubMed ID: 21297032
[TBL] [Abstract][Full Text] [Related]
27. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
[TBL] [Abstract][Full Text] [Related]
28. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.
Souza RF; Shewmake K; Terada LS; Spechler SJ
Gastroenterology; 2002 Feb; 122(2):299-307. PubMed ID: 11832445
[TBL] [Abstract][Full Text] [Related]
29. Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Mol Cell Endocrinol; 2008 Dec; 296(1-2):94-102. PubMed ID: 18771702
[TBL] [Abstract][Full Text] [Related]
30. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
[TBL] [Abstract][Full Text] [Related]
31. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus.
Rawat N; Alhamdani A; McAdam E; Cronin J; Eltahir Z; Lewis P; Griffiths P; Baxter JN; Jenkins GJ
Clin Transl Oncol; 2012 Apr; 14(4):302-11. PubMed ID: 22484638
[TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus: progression to adenocarcinoma and markers.
Fang D; Das KM; Cao W; Malhotra U; Triadafilopoulos G; Najarian RM; Hardie LJ; Lightdale CJ; Beales IL; Felix VN; Schneider PM; Bellizzi AM
Ann N Y Acad Sci; 2011 Sep; 1232():210-29. PubMed ID: 21950815
[TBL] [Abstract][Full Text] [Related]
33. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
34. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
[TBL] [Abstract][Full Text] [Related]
35. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
[TBL] [Abstract][Full Text] [Related]
36. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
38. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
[TBL] [Abstract][Full Text] [Related]
39. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
40. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]